Article
UBE2T is a diagnostic and prognostic biomarker for endometrial cancer
5 Oct 2024
Abstract excerpt
BACKGROUND: Endometrial cancer (UCEC) is one of the most common malignant tumors in gynecology, and early diagnosis is crucial for its treatment. Currently, there is a lack of early screening tests specific to UCEC, and treatment advances are limited. It is crucial to identify more sensitive biomarkers for screening, diagnosis, and predicting UCEC. Previous studies have shown that UBE2T is involved in the...
Topics
Join the communities discussing this publication.
